Werkgroep Cardiologische centra Nederland

RED-HF (Completed)

Reduction of Events with Darbepoetin alfa in Heart Failure. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Subjects With HF and Anemia.
Medicine
darbepoëtine
Population
Heart failure
Phase
III
Starting year
2006
More information
ClinicalTrials.gov

Director of Study

dr. G.C.M. Linssen (Cardioloog)
Almelo, ZGT

RED-HF: News